FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992464037> ?p ?o ?g. }

• W1992464037 endingPage "E1737" @default.
• W1992464037 startingPage "E1732" @default.
• W1992464037 abstract "Recent observational studies have suggested that the use of selective serotonin reuptake inhibitors is associated with an increased fracture risk and an accelerated bone loss, although conflicting results have been reported. Furthermore, because many of these studies have been performed in depressed women, confounding by indication may influence these findings.The objective of the study was to determine whether selective serotonin reuptake inhibitors affect bone metabolism Design: This was a randomized controlled trial.The study was conducted in four US clinical sites.Healthy peri- and postmenopausal women participated in the study.The intervention was escitalopram (10-20 mg/d) for the treatment of vasomotor symptoms.Serum carboxyterminal collagen crosslinks (CTX) and serum amino-terminal propeptide of type I collagen (P1NP) were measured.One hundred forty-one peri- or postmenopausal nondepressed women (mean age 53.7 y, SD 4.1) had baseline and 8-week follow-up samples available for analysis and were included in the study (69 escitalopram, 72 placebo). The groups were balanced across a broad range of baseline characteristics, including age, race, body mass index, smoking status, and mood symptoms. The between-group differences in the change in CTX and P1NP from baseline to week 8 were compared by a repeated-measures linear regression model adjusted for race, clinical center, and baseline measurement. Treatment with escitalopram reduced serum P1NP by 1.02 ng/mL on average [95% confidence interval (CI) -5.17, 3.12] compared with a reduction of 1.88 ng/mL (95% CI -4.82, 1.06) in the placebo group (P = .65). Similarly, serum CTX decreased 0.02 ng/mL on average (95% CI -0.05, 0.01) in the escitalopram group compared with 0.00 ng/mL (95% CI -0.02, 0.02) in the placebo group (P = .24). The results were similar when the analysis was restricted to those women whose adherence to study medication was 70% or greater.Although the study was limited to 8 weeks, these results suggest that escitalopram does not significantly alter bone metabolism in the short term." @default.
• W1992464037 created "2016-06-24" @default.
• W1992464037 creator A5009986689 @default.
• W1992464037 creator A5024994311 @default.
• W1992464037 creator A5041374470 @default.
• W1992464037 creator A5043180253 @default.
• W1992464037 creator A5048654505 @default.
• W1992464037 creator A5068827984 @default.
• W1992464037 creator A5076423165 @default.
• W1992464037 creator A5083313514 @default.
• W1992464037 creator A5089621353 @default.
• W1992464037 date "2014-09-01" @default.
• W1992464037 modified "2023-10-16" @default.
• W1992464037 title "Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial" @default.
• W1992464037 cites W1587066462 @default.
• W1992464037 cites W2008167925 @default.
• W1992464037 cites W2024321527 @default.
• W1992464037 cites W2032052748 @default.
• W1992464037 cites W2033418493 @default.
• W1992464037 cites W2042156452 @default.
• W1992464037 cites W2043274547 @default.
• W1992464037 cites W2043705607 @default.
• W1992464037 cites W2063695744 @default.
• W1992464037 cites W2064301867 @default.
• W1992464037 cites W2074100547 @default.
• W1992464037 cites W2090973045 @default.
• W1992464037 cites W2116800054 @default.
• W1992464037 cites W2132322340 @default.
• W1992464037 cites W2152578289 @default.
• W1992464037 cites W21569453 @default.
• W1992464037 cites W2165209419 @default.
• W1992464037 cites W2482202957 @default.
• W1992464037 cites W51813972 @default.
• W1992464037 doi "https://doi.org/10.1210/jc.2014-2288" @default.
• W1992464037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4154080" @default.
• W1992464037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25014001" @default.
• W1992464037 hasPublicationYear "2014" @default.
• W1992464037 type Work @default.
• W1992464037 sameAs 1992464037 @default.
• W1992464037 citedByCount "20" @default.
• W1992464037 countsByYear W19924640372015 @default.
• W1992464037 countsByYear W19924640372016 @default.
• W1992464037 countsByYear W19924640372017 @default.
• W1992464037 countsByYear W19924640372018 @default.
• W1992464037 countsByYear W19924640372019 @default.
• W1992464037 countsByYear W19924640372020 @default.
• W1992464037 countsByYear W19924640372022 @default.
• W1992464037 countsByYear W19924640372023 @default.
• W1992464037 crossrefType "journal-article" @default.
• W1992464037 hasAuthorship W1992464037A5009986689 @default.
• W1992464037 hasAuthorship W1992464037A5024994311 @default.
• W1992464037 hasAuthorship W1992464037A5041374470 @default.
• W1992464037 hasAuthorship W1992464037A5043180253 @default.
• W1992464037 hasAuthorship W1992464037A5048654505 @default.
• W1992464037 hasAuthorship W1992464037A5068827984 @default.
• W1992464037 hasAuthorship W1992464037A5076423165 @default.
• W1992464037 hasAuthorship W1992464037A5083313514 @default.
• W1992464037 hasAuthorship W1992464037A5089621353 @default.
• W1992464037 hasBestOaLocation W19924640371 @default.
• W1992464037 hasConcept C126322002 @default.
• W1992464037 hasConcept C134018914 @default.
• W1992464037 hasConcept C142724271 @default.
• W1992464037 hasConcept C168563851 @default.
• W1992464037 hasConcept C170033053 @default.
• W1992464037 hasConcept C204787440 @default.
• W1992464037 hasConcept C27081682 @default.
• W1992464037 hasConcept C2779177272 @default.
• W1992464037 hasConcept C2779583969 @default.
• W1992464037 hasConcept C2781161787 @default.
• W1992464037 hasConcept C44249647 @default.
• W1992464037 hasConcept C71924100 @default.
• W1992464037 hasConcept C77350462 @default.
• W1992464037 hasConceptScore W1992464037C126322002 @default.
• W1992464037 hasConceptScore W1992464037C134018914 @default.
• W1992464037 hasConceptScore W1992464037C142724271 @default.
• W1992464037 hasConceptScore W1992464037C168563851 @default.
• W1992464037 hasConceptScore W1992464037C170033053 @default.
• W1992464037 hasConceptScore W1992464037C204787440 @default.
• W1992464037 hasConceptScore W1992464037C27081682 @default.
• W1992464037 hasConceptScore W1992464037C2779177272 @default.
• W1992464037 hasConceptScore W1992464037C2779583969 @default.
• W1992464037 hasConceptScore W1992464037C2781161787 @default.
• W1992464037 hasConceptScore W1992464037C44249647 @default.
• W1992464037 hasConceptScore W1992464037C71924100 @default.
• W1992464037 hasConceptScore W1992464037C77350462 @default.
• W1992464037 hasIssue "9" @default.
• W1992464037 hasLocation W19924640371 @default.
• W1992464037 hasLocation W19924640372 @default.
• W1992464037 hasLocation W19924640373 @default.
• W1992464037 hasLocation W19924640374 @default.
• W1992464037 hasOpenAccess W1992464037 @default.
• W1992464037 hasPrimaryLocation W19924640371 @default.
• W1992464037 hasRelatedWork W1970730570 @default.
• W1992464037 hasRelatedWork W1975979596 @default.
• W1992464037 hasRelatedWork W2022695623 @default.
• W1992464037 hasRelatedWork W2024155257 @default.
• W1992464037 hasRelatedWork W2041938128 @default.
• W1992464037 hasRelatedWork W2105853087 @default.

• next